SPHINGOTEC GROUP
COMBINING INNOVATIVE BIOMARKERS WITH OUTSTANDING TECHNOLOGY
LATEST NEWS
Sphingotec reveals novel results on bioactive adrenomedullin for diagnosis and therapy monitoring of septic shock at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
Learn more
Sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology.